Recent News

• 04.22.2025 - NeoGenomics to Showcase PanTracer LBx Validation Study at AACR Annual Meeting
• 04.08.2025 - ARS - Annual Report to Security Holders
• 04.08.2025 - NeoGenomics to Report First Quarter 2025 Financial Results on April 29, 2025
• 04.07.2025 - NeoGenomics Completes Acquisition of Pathline
• 04.01.2025 - Tony Zook Assumes Role as Chief Executive Officer of NeoGenomics
• 03.18.2025 - NeoGenomics Appoints Warren Stone as President & Chief Operating Officer
• 03.10.2025 - NeoGenomics Expands Oncology Testing Reach in the Northeast with Acquisition of Pathline

Recent Filings

• 04.08.2025 - 8-K Current report
• 04.08.2025 - ARS Annual Report to Security Holders
• 04.08.2025 - DEF 14A Other definitive proxy statements
• 04.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.31.2025 - 8-K/A Current report
• 03.19.2025 - 8-K/A Current report
• 03.18.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 03.18.2025 - 8-K Current report
• 03.18.2025 - EX-99.1 EX-99.1